Transforming Science into Solutions
We are using advanced RNA therapies to transfigure the oncology landscape.
Our focus is safer, more effective treatment options and better patient outcomes.
The Journey of PathFinder Therapeutics
Founded by a pair of scientists and industry experts, PathFinder Therapeutics embarked on its mission in 2024. The founders were driven by a desire to redefine current cancer treatments and use cutting-edge RNA technology to deliver superior care to patients.
Timeline
2024
The Founding
In 2024, PathFinder Therapeutics LLC was established by our two founders Matt and Jack.
Their passion for new therapies and interests in innovative RNA technologies steered PathFinder to create targeted cancer therapies with significantly lower dosage requirements.
2025
The Now
In 2025, our first research grade materials were received.
Our tests commenced, which demonstrated promising results that confirmed the efficacy of our RNA-based treatments.